KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 79 filers reported holding KRONOS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,294,779 | +17.3% | 995,984 | +55.2% | 0.00% | 0.0% |
| Q2 2023 | $1,103,643 | +115585.8% | 641,653 | -1.8% | 0.00% | 0.0% |
| Q1 2023 | $954 | +24.2% | 653,569 | +37.8% | 0.00% | – |
| Q4 2022 | $768 | -99.9% | 474,354 | +68.3% | 0.00% | -100.0% |
| Q3 2022 | $944,000 | -8.4% | 281,910 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $1,031,000 | +388.6% | 283,155 | +869.3% | 0.00% | – |
| Q1 2022 | $211,000 | -71.2% | 29,211 | +16.8% | 0.00% | -100.0% |
| Q1 2021 | $732,000 | -56.9% | 25,013 | -56.0% | 0.00% | 0.0% |
| Q4 2020 | $1,697,000 | – | 56,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
| Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
| Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
| Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
| Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
| Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
| Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
| Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
| Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |